XML 31 R20.htm IDEA: XBRL DOCUMENT v3.21.1

Revenue Recognition and Collaborative Arrangements (Tables)

3 Months Ended

Mar. 31, 2021

Revenue Recognition and Collaborative Arrangements

Schedule of net revenue from collaborative arrangements

Net revenue recognized under our GSK Agreements was as follows:

​

​	​	​	​	​	​	​
​	​	Three Months Ended March 31,
(In thousands)		2021			2020
Royalties from a related party - RELVAR/BREO	​	$	56,390	​	$	56,149
Royalties from a related party - ANORO	​		10,500	​		9,850
Royalties from a related party - TRELEGY	​	​	22,084	​	​	16,135
Total royalties from a related party	​		88,974	​		82,134
Less: amortization of capitalized fees paid to a related party	​		(3,456)	​		(3,456)
Royalty revenue from GSK	​	$	85,518	​	$	78,678

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration